Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 12
Submit an article Journal homepage
379
Views
10
CrossRef citations to date
0
Altmetric
Letter

High-dose melphalan with bortezomib as conditioning regimen for autologous stem cell transplant in patients with newly diagnosed multiple myeloma who exhibited at least very good partial response to bortezomib-based induction therapy

Wenrong HuangDepartment of Hematology, Chinese PLA General Hospital, Beijing, China
,
Jian LiDepartment of Hematology, Peking Union Medical College Hospital, Beijing, China
,
Honghua LiDepartment of Hematology, Chinese PLA General Hospital, Beijing, China
,
Wenying KangDepartment of Hematology, Peking Union Medical College Hospital, Beijing, China
,
Jian BoDepartment of Hematology, Chinese PLA General Hospital, Beijing, China
,
Yu ZhaoDepartment of Hematology, Chinese PLA General Hospital, Beijing, China
,
Chunji GaoDepartment of Hematology, Chinese PLA General Hospital, Beijing, China
,
Daobin ZhouDepartment of Hematology, Peking Union Medical College Hospital, Beijing, China
&
Li YuDepartment of Hematology, Chinese PLA General Hospital, Beijing, ChinaCorrespondence[email protected]
 show all
Pages 2507-2510 | Received 09 Nov 2011, Accepted 12 Apr 2012, Published online: 22 May 2012

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Margarita Blanes, José D. González, Juan J. Lahuerta, Paz Ribas, Ignacio Lorenzo, Blanca Boluda, Miguel A. Sanz & Javier de la Rubia. (2015) Bortezomib-based induction therapy followed by intravenous busulfan–melphalan as conditioning regimen for patients with newly diagnosed multiple myeloma. Leukemia & Lymphoma 56:2, pages 415-419.
Read now
Massimo Martino, Attilio Olivieri, Massimo Offidani, Ernesto Vigna, Tiziana Moscato, Roberta Fedele, Mauro Montanari, Giuseppe Console, Massimo Gentile, Giuseppe Messina, Giuseppe Irrera & Fortunato Morabito. (2013) Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myeloma. Expert Opinion on Investigational Drugs 22:5, pages 619-634.
Read now

Articles from other publishers (8)

Mohammad O Ali & Samer Al Hadidi. (2022) High dose (conditioning) regimens used prior to autologous stem cell transplantation in multiple myeloma. Transplantation and Cellular Therapy 28:9, pages 572-580.
Crossref
Murielle Roussel, Valérie Lauwers-CancesMargaret MacroXavier LeleuBruno RoyerCyrille HulinLionel KarlinAurore Perrot, Cyrille TouzeauMarie-Lorraine ChrétienSophie RigaudeauMamoun DibEmmanuelle Nicolas-VirelizierMartine Escoffre-BarbeKarim BelhadjClara MarietteAnne-Marie StoppaCarla AraujoChantal DoyenJean FontanBrigitte KolbLaurent GarderetSabine BrechignacJean-Valère MalfusonArnaud JaccardPascal LenainCécile BorelBenjamin HebraudOmar BenbrahimVéronique DorvauxSalomon ManierKarine Augeul-MeunierMarie-Christiane VekemansEdouard RandriamalalaDriss ChaouiJo Caers, Carine ChaleteixLofti Benboubker, Laure VincentSylvie GlaisnerPatricia ZunicBorhane SlamaJean-Richard EveillardCatherine Humbrecht-KrautVéronique MorelPhilippe MineurJean-Claude EisenmannHélène DemarquetteValentine RichezMarguerite VignonDenis CaillotThierry FaconPhilippe MoreauAnne-Laurène ColinPascale OlivierSoraya Wuilleme, Hervé Avet-Loiseau, Jill Corre & Michel Attal. (2022) Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study. Blood 139:18, pages 2747-2757.
Crossref
Eda Aypar, Fikret Vehbi İzzettin, Şahika Zeynep Akı, Mesut Sancar, Zeynep Arzu Yeğin & Gülsan Türköz-Sucak. (2017) Comparison of conditioning regimen toxicities among autologous stem cell transplantation eligible multiple myeloma patients: High-dose melphalan versus high-dose melphalan and bortezomib. Journal of Oncology Pharmacy Practice 24:4, pages 281-289.
Crossref
Holly Lee, Peter Duggan, Ahsan Chaudhry, Paola Neri, Jason Tay, Fariborz Rashid-Kolvear, Nizar J. Bahlis & Victor H. Jimenez-Zepeda. (2018) Early Relapse for Multiple Myeloma Patients Undergoing Single Autologous Stem Cell Therapy: A Single-center Experience. Clinical Lymphoma Myeloma and Leukemia 18:1, pages e69-e75.
Crossref
Sergei Vasil'evich Gritsaev, A.A. Kuzyaeva & S.S. Bessmel'tsev. (2017) Certain Aspects of Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma. Clinical oncohematology 10:1, pages 7-12.
Crossref
Bernard Maybury, Gordon Cook, Guy Pratt, Kwee Yong & Karthik Ramasamy. (2016) Augmenting Autologous Stem Cell Transplantation to Improve Outcomes in Myeloma. Biology of Blood and Marrow Transplantation 22:11, pages 1926-1937.
Crossref
Makoto Nakamura & Kazutaka Sunami. (2014) Autologous stem cell transplantation for multiple myeloma. Journal of Hematopoietic Cell Transplantation 3:3, pages 64-78.
Crossref
Toshihiro Miyamoto, Goichi Yoshimoto, Tomohiko Kamimura, Tsuyoshi Muta, Shuichiro Takashima, Yoshikiyo Ito, Motoaki Shiratsuchi, Ilseung Choi, Koji Kato, Katsuto Takenaka, Hiromi Iwasaki, Yasushi Takamatsu, Takanori Teshima & Koichi Akashi. (2013) Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma. International Journal of Hematology 98:3, pages 337-345.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.